NeurAxis, Inc. (NRXS) Research
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
Market snapshot
- Symbol
- NRXS
- Price
- $7.15
- Day change
- +6.56%
- Market cap
- $88.5M
- P/E ratio
- -10.75x
- 52-week range
- 2.196-9.33
- Sector
- Healthcare
- Industry
- Biotechnology
- Next earnings
- in 3 months
- Analyst price target
- $8.00
Peer companies
Recent insider activity
- Aharon Gil — A-Award (221917 shares) on 2026-04-28
- Aharon Gil — A-Award (12304 shares) on 2026-04-28
- Henrichs Timothy Robert — P-Purchase (7593 shares) on 2026-04-01
- Carrico Thomas Joeseph — P-Purchase (667 shares) on 2026-04-01
- Carrico Brian Allen — P-Purchase (8060 shares) on 2026-04-01
Open NeurAxis, Inc. (NRXS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.